109 TREATMENT PROFILE OF AUTOIMMUNE HEPATITIS IN A BRAZILIAN TERTIARY HOSPITAL

by Camila Toledo Turano, Renata da Silva Moutinho, Raul Carlos Wahle, Luiza Alencar Saldanha Queiroz, Claudia de Fatima Gomes Vieira Oliveira, Ana Luisa Vieira Rodrigues De Queiroz, Dora Gama Ribeiro LeiteAltikes, Paula Bechara Poletti
Published 2021-09-01

P-55 QUALITY OF LIFE IMPROVES IN PATIENTS WITH OR WITHOUT CIRRHOSIS AFTER HEPATITIS C CURE WITH DIRECT-ACTING ANTIVIRAL AGENTS

by Lucrecia Garcia Olveira, Sebastián Marciano, Leila Haddad, Monica Fabiola Vasquez Palacios, Diego Giunta, Adrian Gadano
Published 2021-09-01

O-14 A SYNERGISTIC EFFECT OF PNPLA3 GENE POLYMORPHISM AND INSULIN RESISTANCE INCREASES THE RISK TO NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME

by Amanda Recuero, Fernanda Malta, Larissa Gomes, Gustavo Maciel, Paula Salles Ana, Sandra Tochetto, Maria Cristina Chammas, Denise Paranaguá-Vezozzo, Edmund Baracat, José Tadeu Stefano, Alex Cassenote, João Renato Pinho, Flair Carrilho, Oliveira Claudia P.
Published 2021-09-01

P-88 EVALUATION OF STEATOSIS AND LIVER FIBROSIS IN PATIENTS WITH PSORIASIS: THE IMPACT OF METHOTREXATE AND METABOLIC FACTORS ON THE SEVERITY OF THE DISEASE

by Luciana Agoglia, Ana Carolina Cardoso, Nathalie Leite C., Maria Chiara Chindamo, Cristiane A. Villela-Nogueira
Published 2021-09-01

P-34 OUTCOME OF HEPATITIS C TREATMENT WITH DIRECT-ACTING ANTIVIRALS AFTER UNIVERSAL ACCESS TO THERAPY

by S. Blanco-Sampascual, I. Gorostiza-Hormaetxe, F. Menéndez-Blázquez, P. Ruiz-Eguiluz, A. Baranda-Martín, A. Castrillo-Olabarria, M.A. Gómez-Suárez, A. Calderón-García
Published 2021-09-01

P-33 EVALUATION OF CIRCULATING METABOLOME IN THE SEARCH OF POTENTIAL DRUG-INDUCED LIVER INJURY BIOMARKERS

by Daniel E. Di Zeo-Sánchez, Inmaculada Medina-Cáliz, Judith Sanabria-Cabrera, Miren Garcia-Cortes, Aida Ortega-Alonso, Alejandro Cueto-Sanchez, Rocio San Juan-Jimenez, Andrés Gonzalez-Jimenez, Ismael Álvares-Álvarez, Hao Niu, Cristina Alonso, Guruprasad P Aithal, Raul J. Andrade, M. Isabel Lucena, Mercedes Robles-Diaz
Published 2021-09-01

O-23 METABOLIC ASSOCIATED FATTY LIVER DISEASE CLINICAL PROFILE IN LEAN PATIENTS: CAN IT BE DIFFERENT?

by Andreza Rosa Cabral, Ana Rafaela S. Do Vale, Naiades S. Almeida, Raquel Rocha, Antonio Ricardo C.F. de Andrade, Ana Cristina Landin, Helma P. Cotrim
Published 2021-09-01

P-56 LOW ROLE OF NON-INVASIVE FIBROSIS ASSESSMENT USING FIB-4 AND APRI IN PATIENTS WITH AUTOIMMUNE HEPATITIS

by Aline Lamaison, Javier Troncoso, Pablo Villafranca, Marcel Bonilla, Maximo Cattaneo, Laura Carreño, Jaime Poniachik, Alvaro Urzúa
Published 2021-09-01

P-82 URSODEOXYCHOLIC ACID AND/OR CIPROFIBRATE FOR TREATING PATIENTS WITH PRESUMPTIVE DIAGNOSIS OF LOW PHOSPHOLIPID CHOLELITHIASIS, A CLINICAL SPECTRUM OF PROGRESSIVE FAMILIAL INTRA...

by Fernanda Linahres, Debora Terrabuio, Michelle Braga, Laura Guedes, Flair Jose Carrilho, Eduardo Cancado
Published 2021-09-01

P-91 PREVALENCE OF HEPATITIS C VIRUS INFECTION DETECTED BY RAPID TEST IN A HIGH-RISK POPULATION

by Pedro Montes Teves, Briny Rodriguez Vargas, Jaime Fustamante Flores, Eduardo Monge Salgado
Published 2021-09-01

O-18 IMPAIRED ANTI-HBV VACCINE RESPONSE IN NON-CIRRHOTIC CHRONIC HCV PATIENTS IS NOT OVERCOME BY DOUBLE DOSE REGIMEN. FOURTH DOSE MAYBE THE ANSWER!

by Roseane Pôrto Medeiros, Norah A. Terrault, Daniel F. Mazo, Claudia P. Oliveira, Jennifer L. Dodge, Patricia M. Zitelli, M. Lopes, Flair J. Carrilho, Mário Guimarães Pessoa
Published 2021-09-01

P-25 SLOWER FIBROSIS PROGRESSION IN HEPATITIS C HEMOPHILIAC PATIENTS?

by Dauana O. Bastos, Christini Emori, Sandra V. Antunes, Flavia Appel, Maria Lucia Ferraz
Published 2021-09-01

P-12 QUALITATIVE EVALUATION OF NATURAL PRODUCTS USED BY PATIENTS IN A BRAZILIAN HEPATOTOXICITY AMBULATORY

by Caio Medina Lopes, Andréia de Santana Souza, Ademir do Vale, Juceni Pereira David, Genario Santos, Vinicius Santos Nunes, Maria Isabel Schinoni, Raymundo Paraná
Published 2021-09-01

P-47 HISTOPATHOLOGICAL ANALYSIS OF 10-YEAR PROTOCOL LIVER ALLOGRAFT BIOPSY OF ASYMPTOMATIC PEDIATRIC RECIPIENTS FROM A SINGLE BRAZILIAN CENTER

by Luciana E. Soares, Carlos Thadeu Carski, Carlos O. Kieling, Marina Adami, Renata Rostirola Guedes, Ariane Backes, Ian Leipnitz, Sandra M.G. Vieira
Published 2021-09-01

P-9 SAFETY AND EFFECTIVENESS OF DIRECT ACTING AGENTS FOR HCV TREATMENT AFTER LIVER TRANSPLANTATION IN RIO DE JANEIRO (BRAZIL)

by L.C.M. Pinto, E. Balbi, Halpern, L.P. Carius, J. Roma, L.F.P. Moreira, H. Perazzo
Published 2021-09-01

P-37 EXPERIENCE IN MEXICO WITH DIRECT ACTING ANTIVIRALS AS A TREATMENT FOR HEPATITIS C

by J.L. Pérez Hernández, Aldo Torre Delgadillo, Graciela Castro Narro, Eira Cerda Reyes, Mayra Virginia Ramos Gómez, Leonardo Juárez Chávezx, Margarita Dehesa Violante, Linda Muñoz Espinosa, Laura Cisneros Garza, Ignacio Aiza Haddad, José Antonio Velarde Ruiz Velasco, Raul Contreras Omaña, Nancy García Casarreal, Armando Carmona Castañea José, María de Fátima Higuera de la Tijera
Published 2021-09-01

P-41 TRENDS IN HOSPITALIZATION, CHARACTERISTICS AND MORTALITY OF HOSPITALIZED PATIENTS WITH CIRRHOSIS IN CHILE

by Juan Pablo Roblero, Juan Pablo Arab, Christian Von Muhlenbrock, Pablo Roblero, Jaime Poniachik
Published 2021-09-01

P-15 WAITING LIST FOR LIVER TRANSPLANTATIOS: CLINICAL AND ECONOMIC BURDEN, RETROSPECTIVE STUDY

by Santiago Rodríguez, Fabio Da Motta, Giacomo Balbinoto Neto, Ajacio Brandão
Published 2021-09-01

P-22 ANALYSIS OF FEATURES ASSOCIATED WITH DIFFICULTY IN SCREENING AND EARLY DIAGNOSING HEPATOCELLULAR CARCINOMA IN RISK PATIENTS

by João Eugênio Loureiro Lopes, Júlia Antunes RizzoBicalho, Livia Zardo Trindade, Mariana Poltronieri Pacheco
Published 2021-09-01

P-120 NATIONAL SURVEY ON CURRENT PRACTICES TO PREVENT HBV REACTIVATION DURING IMMUNOSUPPRESSION

by J.M. Araujo-Neto, M. Iasi, L.C. Nabuco, F.S.R.P. Pessoa, E. Vilela, R. Stucchi, L.Y. Sassaki, A.K.G. Melo, A.C.S. Jesus, J.F. Ramos, M.I. Braghiroli, G. Pilleggi, D.M. Langhi-Junior, A.K. Coutinho, M.L. Ferraz, P.L. Bitencourt, C.E. Brandão
Published 2021-09-01